Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00271830 · ClinicalTrials.gov registry record

Sexual Function in Male Renal Transplant Patients

A clinical trial, sponsored by Montefiore Medical Center.

Terminated
Registry status
110
Enrollment target

NCT00271830: Clinical Trial study, sponsored by Montefiore Medical Center.

NCT00271830 is a clinical trial that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00271830 was terminated before completion, sponsored by Montefiore Medical Center.

TERMINATED
Registry status
110 participants
Enrollment target

Study Summary

Sexual dysfunction is common in male patients with chronic renal failure on dialysis and after renal trasnplantation. Multiple factors play a role in this important clinical problem. Recent studies suggest that certain immunosuppressive medication used for solid organ transplant may affect male sexual function. The purpose of this study is to compare the sexual function of male renal transplant patients on sirolimus and those patients not on sirolimus immunosuppression.

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2006-01
Est. Completion 2007-08
Montefiore Medical Center

345 total trials

Why NCT00271830 stopped before completion

NCT00271830 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00271830 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00271830 about?

NCT00271830 is a clinical study titled "Sexual Function in Male Renal Transplant Patients". Sexual dysfunction is common in male patients with chronic renal failure on dialysis and after renal trasnplantation. Multiple factors play a role in this important clinical problem. Recent studies suggest that certain immunosuppressive medication used for solid organ transplant may affect male sexu...

What is the current status of trial NCT00271830?

This trial is currently terminated. The enrollment target is 110 participants. The study started on 2006-01. Estimated completion is 2007-08.

Who is sponsoring clinical trial NCT00271830?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00271830, the US trial registry maintained by the National Library of Medicine. NCT00271830 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.